Immunovant stockholders elect directors, ratify auditor, approve say-on-pay at 2022 annual meeting

Immunovant, Inc.

Three directors elected: Peter Salzmann, Douglas Hughes, George Migausky — all with >90M votes for.
Ernst & Young LLP ratified as independent auditor for FY ending March 31, 2023 (105.8M for, 33k against).
Non-binding advisory approval of named executive officer compensation passed with 87.5M for, 14.8M against.
Approximately 91% of shares entitled to vote were represented at the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.